Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008
Published online before print September 18, 2008, doi: 10.1161/CIRCRESAHA.108.176024
A more recent version of this article appeared on October 24, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
103/9/992    most recent
CIRCRESAHA.108.176024v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wright, C. D.
Right arrow Articles by O'Connell, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wright, C. D.
Right arrow Articles by O'Connell, T. D.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PRAZOSIN HYDROCHLORIDE
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Receptor pharmacology

Submitted on November 2, 2007
Revised on August 28, 2008
Accepted on September 4, 2008

Nuclear {alpha}1-Adrenergic Receptors Signal Activated ERK Localization to Caveolae in Adult Cardiac Myocytes

Casey D. Wright ; Quanhai Chen ; Nichole L. Baye ; Yuan Huang ; Chastity L. Healy ; Sivakanthan Kasinathan ; and Timothy D. O'Connell *

From the Cardiovascular Research Center, Sanford Research/University of South Dakota, Sioux Falls.

* To whom correspondence should be addressed. E-mail: oconnelt{at}sanfordhealth.org.

We previously identified an {alpha}1-AR-ERK ({alpha}1A-adrenergic receptor–extracellular signal-regulated kinase) survival signaling pathway in adult cardiac myocytes. Here, we investigated localization of {alpha}1-AR subtypes ({alpha}1A and {alpha}1B) and how their localization influences {alpha}1-AR signaling in cardiac myocytes. Using binding assays on myocyte subcellular fractions or a fluorescent {alpha}1-AR antagonist, we localized endogenous {alpha}1-ARs to the nucleus in wild-type adult cardiac myocytes. To clarify {alpha}1 subtype localization, we reconstituted {alpha}1 signaling in cultured {alpha}1A- and {alpha}1B-AR double knockout cardiac myocytes using {alpha}1-AR–green fluorescent protein (GFP) fusion proteins. Similar to endogenous {alpha}1-ARs and {alpha}1A- and {alpha}1B-GFP colocalized with LAP2 at the nuclear membrane. {alpha}1-AR nuclear localization was confirmed in vivo using {alpha}1-AR-GFP transgenic mice. The {alpha}1-signaling partners G{alpha}q and phospholipase C{beta}1 also colocalized with {alpha}1-ARs only at the nuclear membrane. Furthermore, we observed rapid catecholamine uptake mediated by norepinephrine-uptake-2 and found that {alpha}1-mediated activation of ERK was not inhibited by a membrane impermeant {alpha}1-blocker, suggesting {alpha}1 signaling is initiated at the nucleus. Contrary to prior studies, we did not observe {alpha}1-AR localization to caveolae, but we found that {alpha}1-AR signaling initiated at the nucleus led to activated ERK localized to caveolae. In summary, our results show that nuclear {alpha}1-ARs transduce signals to caveolae at the plasma membrane in cardiac myocytes.


Key words: {alpha}1-adrenergic receptors • cardiac myocytes • ERK